Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    11474665 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
Conditions: Iron Deficiency Anemia;   Subclinical Hypothyroidism
Interventions: Drug: Ferrous sulfate tablets 325 mg, po, TID;   Drug: Ferrous sulfate plus levothyroxine
To Top

† Indicates status has not been verified in more than two years